Lamya Shihabuddin
27Patents
9h-index
19Co-inventors
68Inventor score
Filing activity: Nov 2, 2007 → Mar 26, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8980853B2 | Compositions and methods for modulation of SMN2 splicing in a subject | Chemistry; Metallurgy | 30 | Active |
| US9273315B2 | Modulation of huntingtin expression | Chemistry; Metallurgy | 20 | Active |
| US9034836B2 | Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders | Chemistry; Metallurgy | 20 | Active |
| US9717750B2 | Compositions and methods for modulation of SMN2 splicing in a subject | Chemistry; Metallurgy | 19 | Active |
| US8454954B2 | Treatment of synucleinopathies | Chemistry; Metallurgy | 17 | Active |
| US10369193B2 | Gene therapy for neurodegenerative disorders | Chemistry; Metallurgy | 14 | Active |
| US8926967B2 | Intraventricular enzyme delivery for lysosomal storage diseases | Chemistry; Metallurgy | 11 | Active |
| US9415119B2 | Gene therapy for neurodegenerative disorders | Chemistry; Metallurgy | 11 | Active |
| US10213494B2 | Treatment of synucleinopathies | Chemistry; Metallurgy | 11 | Active |
| US8906873B2 | Modulation of huntingtin expression | Chemistry; Metallurgy | 6 | Active |
| US10080783B2 | Intraventricular enzyme delivery for lysosomal storage diseases | Chemistry; Metallurgy | 6 | Active |
| US10744210B2 | Gene therapy for spinal cord disorders | Chemistry; Metallurgy | 4 | Active |
| US10821154B2 | Compositions and methods for treating spinal muscular atrophy | Chemistry; Metallurgy | 4 | Active |
| US9683236B2 | Modulation of huntingtin expression | Chemistry; Metallurgy | 4 | Active |
| US11253485B2 | Slow intraventricular delivery | Chemistry; Metallurgy | 3 | Active |
| US10202603B2 | Modulation of huntingtin expression | Chemistry; Metallurgy | 2 | Active |
| US11911440B2 | Gene therapy for neurodegenerative disorders | Chemistry; Metallurgy | 2 | Active |
| US10619158B2 | Modulation of huntingtin expression | Chemistry; Metallurgy | 2 | Active |
| US10837016B2 | Modulation of huntingtin expression | Chemistry; Metallurgy | 2 | Active |
| US11975043B2 | Gene therapy for neurodegenerative disorders | Chemistry; Metallurgy | 1 | Active |
| US9314512B2 | Treatment of synucleinopathies | Chemistry; Metallurgy | 1 | Active |
| US11421231B2 | Modulation of Huntington expression | Chemistry; Metallurgy | 1 | Active |
| US11554161B2 | Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders | Chemistry; Metallurgy | 0 | Active |
| US9101623B2 | Treatment of synucleinopathies | Chemistry; Metallurgy | 0 | Active |
| US12350311B2 | Gene therapy for neurodegenerative disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.